Company Filing History:
Years Active: 2015
Title: The Innovations of Nora Torres-Nagel
Introduction
Nora Torres-Nagel is an accomplished inventor based in Habach, Germany, known for her significant contributions to the field of biotechnology. With a focus on innovative medical applications, she has made a mark as a notable figure in research and development.
Latest Patents
Nora is recognized for holding a patent for her invention titled "Antibodies against human EPO receptor." This patent describes an antibody that binds to the human EPO receptor, specifically targeting the phosphorylated tyrosine residues pY461, pY430, or pY465. The development of this antibody is pivotal for determining the activation state of the EPO receptor, which has implications in medical diagnostics and therapeutic applications.
Career Highlights
Torres-Nagel works at Hoffmann-La Roche Inc., a leading global healthcare company that emphasizes innovative approaches in biotechnology and pharmaceutical development. Throughout her career, she has shown dedication to advancing scientific knowledge and improving healthcare solutions through her inventive work.
Collaborations
In her professional journey, Nora has collaborated with esteemed colleagues, including Michael Jarsch and Manfred Kubbies. These collaborations enhance her research efforts and bolster the innovative environment at Hoffmann-La Roche Inc., contributing to advancements in biotherapeutics.
Conclusion
Nora Torres-Nagel's contributions to the field of biotechnology and her patent on antibodies against the human EPO receptor illustrate her role as an impactful inventor. Her work continues to inspire innovation and drive collaboration in the scientific community, paving the way for future advancements in medicine.